Skip to main content

Table 1 Characteristics of the study population of patients tested for COVID-19

From: Renin-angiotensin system modulators and other risk factors in COVID-19 patients with hypertension: a Korean perspective

Characteristics

Patients with hypertension

(N = 75,527)

All patients

(N = 234,427)

Median age (interquartile rage)- yr.

68 (23)

45 (35)

Female sex – no. (%)

35,761 (47.3)

122,480 (52.2)

Confirmed COVID-19- no. (%)

1911 (2.5)

7590 (3.2)

Diabetes mellitus- no. (%)

44,441 (58.8)

62,655 (26.7)

Cardiovascular disease- no. (%)

4705 (6.2)

5038 (2.1)

Cerebrovascular disease- no. (%)

14,503 (19.2)

17,519 (7.5)

Ischemic heart disease- no. (%)

12,122 (16)

14,191 (6.1)

COPD- no. (%)

4871 (6.4)

6612 (2.8)

Malignancy- no. (%)

14,368 (19)

24,628 (10.5)

Renal replacement therapy- no. (%)

4338 (5.7)

4525 (1.9)

ACEIs or ARBs- no. (%)

13,116 (17.4)

13,240 (5.6)